Cargando…

Challenges of Genomic Testing for Hereditary Breast and Ovarian Cancers

Completion of genetic testing is increasingly important for the complex care of patients with suspected hereditary breast and ovarian cancers (HBOC) and their at-risk family members. Identification of individuals with pathogenic variants has implications for targeted treatment recommendations, risk...

Descripción completa

Detalles Bibliográficos
Autores principales:	McAlarnen, Lindsey, Stearns, Kristen, Uyar, Denise
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814235/ https://www.ncbi.nlm.nih.gov/pubmed/33488111 http://dx.doi.org/10.2147/TACG.S245021

Ejemplares similares

A case series of triplet anti-hormonal therapy in androgen receptor-positive recurrent adult ovarian granulosa cell tumor()
por: Summey, Rebekah M., et al.
Publicado: (2022)

Extracellular vesicle contents as non-invasive biomarkers in ovarian malignancies
por: McAlarnen, Lindsey A., et al.
Publicado: (2022)

Internet and Free Press Are Associated with Reduced Lags in Global Outbreak Reporting
por: McAlarnen, Lindsey, et al.
Publicado: (2014)

Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance
por: Parashar, Deepak, et al.
Publicado: (2022)

Correction: Parashar et al. Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance. Cancers 2022, 14, 958
por: Parashar, Deepak, et al.
Publicado: (2022)

Hereditary breast and ovarian cancer
por: Gronwald, Jacek, et al.
Publicado: (2008)

Virtual visits among gynecologic oncology patients during the COVID-19 pandemic are accessible across the social vulnerability spectrum
por: McAlarnen, Lindsey A., et al.
Publicado: (2021)

Acute cardiopulmonary failure in a young woman with high-risk gestational trophoblastic neoplasia: A case of induction chemotherapy during extracorporeal membrane oxygenation
por: McAlarnen, Lindsey A., et al.
Publicado: (2021)

Hereditary Breast-Ovarian Cancer Syndrome in Russia
por: Sokolenko, A.P., et al.
Publicado: (2010)

Salvage treatment in recurrent endometrial cancer of the pelvis and peritoneal cavity
por: McAlarnen, Lindsey A., et al.
Publicado: (2019)

Intrafamilial disclosure of risk for hereditary breast and ovarian cancer: points to consider
por: Black, Lee, et al.
Publicado: (2012)

An Overview on Radiation Sensitivity in Hereditary Breast and Ovarian Cancer Syndrome
por: Gonçalves, Diana, et al.
Publicado: (2022)

Pathology of Hereditary Breast and Ovarian Cancer
por: Hodgson, Anjelica, et al.
Publicado: (2020)

BRCA Genetic Test and Risk-Reducing Salpingo-Oophorectomy for Hereditary Breast and Ovarian Cancer: State-of-the-Art
por: Sekine, Masayuki, et al.
Publicado: (2021)

Mutation Patterns in Portuguese Families with Hereditary Breast and Ovarian Cancer Syndrome
por: Vicente, Rodrigo, et al.
Publicado: (2022)

Genetic Testing in Hereditary Breast and Ovarian Cancer Using Massive Parallel Sequencing
por: Ruiz, Anna, et al.
Publicado: (2014)

Genetic Counselling and Testing for Hereditary Breast and Ovarian Cancer: The Gent(le) Approach
por: De Vos, M., et al.
Publicado: (1999)

The Cost-Effectiveness of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer in Norway
por: Asphaug, Lars, et al.
Publicado: (2019)

Population prevalence of individuals meeting criteria for hereditary breast and ovarian cancer testing
por: Greenberg, Samantha, et al.
Publicado: (2019)

Public Health Approaches and Barriers to Educating Providers about Hereditary Breast and Ovarian Cancer Syndrome
por: Trepanier, Angela M., et al.
Publicado: (2016)

Advocate's Viewpoint on Hereditary Breast/Ovarian Cancer
por: Kolling-Dandrieu, Francisca Bach
Publicado: (2004)

Educational Case: Hereditary breast and ovarian cancers
por: Givi, Jerome P., et al.
Publicado: (2023)

Provider’s Perceptions of Barriers and Facilitators for Latinas to Participate in Genetic Cancer Risk Assessment for Hereditary Breast and Ovarian Cancer
por: Hurtado-de-Mendoza, Alejandra, et al.
Publicado: (2018)

The role of BRCA1/2 in hereditary and familial breast and ovarian cancers
por: Hawsawi, Yousef M., et al.
Publicado: (2019)

Tumor Derived Extracellular Vesicles Drive T Cell Exhaustion in Tumor Microenvironment through Sphingosine Mediated Signaling and Impacting Immunotherapy Outcomes in Ovarian Cancer
por: Gupta, Prachi, et al.
Publicado: (2022)

Criteria of the German Consortium for Hereditary Breast and Ovarian Cancer for the Classification of Germline Sequence Variants in Risk Genes for Hereditary Breast and Ovarian Cancer
por: Wappenschmidt, Barbara, et al.
Publicado: (2020)

SEOM clinical guidelines in Hereditary Breast and ovarian cancer
por: Llort, G., et al.
Publicado: (2015)

Accelerated geroncogenesis in hereditary breast-ovarian cancer syndrome
por: Menendez, Javier A., et al.
Publicado: (2016)

Secondary Prevention in Hereditary Breast and/or Ovarian Cancer Syndromes Other Than BRCA
por: Piombino, Claudia, et al.
Publicado: (2020)

Testing a deliberative democracy method with citizens of African ancestry to weigh pros and cons of targeted screening for hereditary breast and ovarian cancer risk
por: Guan, Yue, et al.
Publicado: (2022)

Ovarian cancer resistance to PARPi and platinum-containing chemotherapy
por: Summey, Rebekah, et al.
Publicado: (2022)

TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge
por: Grill, Sabine, et al.
Publicado: (2020)

Factors associated with genetic testing distress in patients tested for Lynch Syndrome or Hereditary Breast and Ovarian Cancer Syndrome
por: Rosenblatt, Margery, et al.
Publicado: (2011)

Multi gene panel testing for hereditary breast cancer - is it ready to be used?
por: Catana, Andreea, et al.
Publicado: (2019)

Exon splicing analysis of intronic variants in multigene cancer panel testing for hereditary breast/ovarian cancer
por: Ryu, Jin‐Sun, et al.
Publicado: (2020)

The Pathology of Hereditary Breast Cancer
por: Honrado, Emiliano, et al.
Publicado: (2004)

Beyond the pill: contraception and the prevention of hereditary ovarian cancer
por: Xia, Yue Yin, et al.
Publicado: (2022)

The Prevention of Hereditary Breast and Ovarian Cancer: A Personal View
por: Narod, Steven
Publicado: (2004)

Challenges for clinical application of “TRACEBACK” study: testing of historical Tubo-Ovarian cancer patients for hereditary risk genes
por: Sekine, Masayuki, et al.
Publicado: (2023)

Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States
por: Guzauskas, Gregory F., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_osamv9u6hp502oarhul98l6dj3